Protection against tick-borne encephalitis (TBE) for people living in and travelling to TBE-endemic areas

Travel Medicine and Infectious Disease

Volumn 6, Issue 6, 2008, Pages 331-341

  Banzhoff, Angelika ^a   Bröker, Michael ^a   Zent, Olaf ^a  

^a Pharmaserv GmbH and Co KG   (Germany)

Author keywords

Arbovirus; Flavivirus; Tick borne encephalitis; Tourism; Travel; Vaccine

Indexed keywords

FSME IMMUN; PLACEBO; TICK BORNE ENCEPHALITIS VACCINE; TICOVAC; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANOREXIA; ARTICLE; BRAIN PROTECTION; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENDEMIC DISEASE; HIGH RISK POPULATION; HUMAN; IMMUNOGENICITY; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INJECTION SITE PAIN; INJECTION SITE SWELLING; LABORATORY DIAGNOSIS; LEISURE; MALAISE; MASS IMMUNIZATION; MYALGIA; NONHUMAN; PASSIVE IMMUNIZATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; SEASONAL VARIATION; SKIN REDNESS; SLEEP DISORDER; SYSTEMIC DISEASE; TICK BITE; TICK BORNE ENCEPHALITIS; TRAVEL; UNSPECIFIED SIDE EFFECT; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

ANIMALS; BITES AND STINGS; ENCEPHALITIS, TICK-BORNE; ENDEMIC DISEASES; EUROPE; HUMANS; INCIDENCE; TICKS; TRAVEL; VACCINATION; VIRAL VACCINES;

EID: 54949157601     PISSN: 14778939     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmaid.2008.06.011     Document Type: Article

References (81)

1. Kunze M., and Kunze U. Social marketing and the establishment of the ISW-TBE. Vaccine 21 Suppl. 1 (2003) S62-S65
2. Bröker M., and Gniel D. New foci of tick-borne encephalitis virus in Europe: consequences for travellers from abroad. Travel Med Infect Dis 1 (2003) 181-184
3. Haglund M., Settergren B., Heinz F.X., Günther G., and ISW-TBE Study Group. Report of the Meningitis Program of the International Scientific Working Group on TBE: serological screening of patients with viral CNS-infection of unknown etiology in search of undiagnosed TBE cases. Vaccine 21 Suppl. 1 (2003) S166-S172
4. Rendi-Wagner P. Risk and prevention of tick-borne encephalitis in travelers. J Travel Med 11 (2004) 307-312
5. Kunze U., and ISW-TBE. Conference report of the ninth meeting of the International Scientific Working Group of Tick Borne Encephalitis (ISW TBE): tick-borne encephalitis - from epidemiology to current vaccination recommendations. Vaccine 25 (2007) 8350-8351
6. Anonymous. Nurses underestimate TBE prevalence.
7. Dumpis U., Crook D., and Oksi J. Clin Infect Dis 28 (1999) 882-890
8. Kerbo N., Donchenko I., Kutsar K., and Vasilenk V. Eurosurveillance 10 6 (2005)
9. Barrett P.N., Schober-Bendixen S., and Ehrlich H.J. History of TBE vaccines. Vaccine 21 Suppl. 1 (2003) S41-S49
10. Ecker M., Allison S., Meixner T., and Heinz F.X. Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol 80 (1999) 179-185
11. Süss J. Epidemiology and ecology of TBE relevant to the production of effective vaccines. Vaccine 21 Suppl. 1 (2003) S19-S35
12. Poponnikova T.V. Specific clinical and epidemiological features of tick-borne encephalitis in Western Siberia. Int J Med Microbiol 296 Suppl. 1 (2006) 59-62
13. Jääskeläinen A.E., Tikkakoski T., Uzcátegui N.Y., Alekseev A.N., Vaheri A., and Vapalahti O. Siberian subtype tickborne encephalitis virus, Finland. Emerging Infect Dis 12 (2006) 1568-1571
14. Golovljova I., Katargina O., Geller J., Tallo T., Mittženko V., Vene S., et al. Unique signature amino acid substitution in Baltic tick-borne encephalitis virus (TBEV) strains within the Siberian TBEV subtypes. Int J Med Microbiol 298 Suppl. 1 (2008) S108-S120
15. World Health Organization. International travel and health (2007). http://www.who.int
16. World Health Organization. The vector-borne human infections of Europe: their distribution and burden on public health (2004), WHO Regional Office for Europe, Copenhagen
17. Randolph S.E. Tick-borne encephalitis incidence in Central and Eastern Europe: multi-factorial environmental and socio-economic causes. Microbes Infect 10 (2008) 209-216
18. Süss J., Klaus C., Gerstengarbe F.-W., and Werner P.C. What makes ticks tick? Climate change, ticks, and tick-borne diseases. J Travel Med 15 (2008) 39-45
19. Süss J., Klaus C., Diller R., Schrader C., Wohanka N., and Abel U. TBE incidence versus virus prevalence and increased prevalence of the TBE virus in Ixodes ricinus removed from humans. Int J Med Microbiol 296 Suppl. 1 (2006) 63-68
20. Danielová V., Holubová J., and Daniel M. Tick-borne encephalitis virus prevalence in Ixodes ricinus ticks collected in high risk habitats of the south-Bohemian region of the Czech Republic. Exp Appl Acarol 26 (2002) 145-151
21. Matile H., Ferrari E., Aeschlimann A., and Wyler R. The transmission of tick-borne encephalitis in Switzerland. An attempt at establishing a register of natural reservoirs for a seroepidemiological examination of forest personnel in the middle of the country. Schweiz Med Wochenschr 111 (1981) 1262-1269
22. Sumilo D., Asokliene L., Bormane A., Vasilenko V., Golovljova I., and Randolph S.E. Climate change cannot explain the upsurge of tick-borne encephalitis in the Baltics. PLoS ONE 2 6 (2007 Jun6) e500
23. Lindgren E., and Gustafson R. Tick-borne encephalitis in Sweden and climate change. Lancet 358 (2001) 16-18
24. Randolph S.E. Evidence that climate change has caused 'emergence' of tick-borne diseases in Europe?. Int J Med Microbiol 293 Suppl. 37 (2004) 5-15
25. Schneider H. Über epidemische akute "Meningitis serosa". Wien Klin Wochenschr 44 (1931) 350-352
26. Günther G., Haglund M., Lindquist L., Forsgren M., and Sköldenberg B. Tick-borne encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: a prospective study of clinical course and outcome. J Neurol 244 (1997) 230-238
27. Kaiser R. The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-8: a prospective study of 656 patients. Brain 122 (1999) 2067-2078
28. Gritsun T.S., Lashkevich V.A., and Gould E.A. Tick-borne encephalitis. Antiviral Res 57 (2003) 129-146
29. Schultze D., Dollenmaier G., Rohner A., Guidi T., and Cassinotti P. Benefit of detecting tick-borne encephalitis viremia in the first phase of illness. J Clin Virol 38 (2007) 172-175
30. Haglund M., and Günther G. Tick-borne encephalitis - pathogenesis, clinical course and long-term follow-up. Vaccine 21 Suppl. 1 (2003) S11-S18
31. Vene S., Haglund M., Lundkvist A., Lindquist L., and Forsgren. Study of the serological response after vaccination against tick-borne encephalitis in Sweden. Vaccine 25 (2007) 366-372
32. Zenz W., Pansi H., Zoehrer B., Mutz I., Holzmann H., Kraigher A., et al. Tick-borne encephalitis in children in Styria and Slovenia between 1980 and 2003. Pediatr Infect Dis J 24 (2005) 892-896
33. Fritsch P., Gruber-Sedlmayr U., Pansi H., Zöhrer B., Mutz I., Spork D., et al. Tick-borne encephalitis in Styrian children from 1981 to 2005: a retrospective study and a review of the literature. Acta Paediatr 97 (2008) 535-538
34. RKI. Anmerkungen zur FSME im Kindesalter. Epidemiol Bull 16 (2001) 109
35. Heiniger U. Frühsommer-Meningoencephalitis (FSME) - Ein zunehmendes Problem in der Schweiz. Ars Medici 3 (2006) 101-104
36. Holmgren E.B., and Forsgren M. Epidemiology of tick-borne encephalitis in Sweden 1956-89: a study of 1116 cases. Scand J Infect Dis 22 (1990) 287-295
37. Sonnenberg K., Niedrig M., Steinhagen K., Rohwäder E., Meyer W., Schlumberger W., et al. State-of-the-art serological techniques for detection of antibodies against tick-borne encephalitis virus. Int J Med Microbiol 293 Suppl. 37 (2004) 148-151
38. Niedrig M., Vaisviliene D., Teichmann A., Klockmann U., and Biel S.S. Comparison of six different commercial IgG-ELISA kits for the detection of TBEV-antibodies. J Clin Virol 20 (2001) 179-182
39. Niedrig M., Avšič T., Aberle S.W., Ferenczi, Labuda M., Rozentale B., et al. Quality control assessment for the serological diagnosis of tick borne encephalitis virus infections. J Clin Virol 38 (2007) 260-264
40. Donoso Mantke O., Aberle S.W., Avšič-Županc T., Labuda M., and Niedrig M. Quality control assessment for the PCR diagnosis of tick-borne encephalitis virus infections. J Clin Virol 38 (2007) 73-77
41. Donoso Mantke O., Aberle S.W., Avšič-Županc T., Libuda M., Ferenczi E., Rozentale B., et al. External quality assurance studies for the serological and PCR diagnostics of tick-borne encephalitis virus infections. Int J Med Microbiol 298 Suppl. 1 (2008) S333-S335
42. Růžek D., Št'astná H., Kopecký J., Golovljova I., and Grubhoffer L. Rapid subtyping of tick-borne encephalitis virus isolates using multiplex RT-PCR. J Virol Methods 144 (2007) 133-137
43. Zent O., and Bröker M. Tick-borne encephalitis vacciones: past and present. Expert Rev Vaccines 4 (2005) 747-755
44. ® Adult for induction of human neutralizing antibodies against recent Far Eastern subtype strains of tick-borne encephalitis virus. Vaccine 25 (2007) 895-901
45. Klockmann U., Křivanec K., Stephenson J.R., and Hilfenhaus J. Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine. Vaccine 9 (1991) 210-212
46. Hayasaka D., Goto A., Yoshii K., Mizutani T., Kariwa H., and Takashima I. Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and Far-eastern subtype strains. Vaccine 19 (2001) 4774-4779
47. Zent O., Hennig R., Banzhoff A., and Bröker M. Protection against tick-borne encephalitis with a new vaccine formulation free of protein-derived stabilizers. J Travel Med 12 (2005) 85-93
48. Marth E., and Kleinhappl B. Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination. Vaccine 20 (2001) 532-537
49. Pavlova B.G., Löw-Baselli A., Fritsch S., Pöllabauer E.M., Vartian N., Rinke I., et al. Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN "NEW" in children: results of post-marketing surveillance. Vaccine 21 (2003) 742-745
50. Girgsdies O.E., and Rosenkranz G. Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study. Vaccine 14 (1996) 1421-1428
51. Zent O., and Hennig R. Post-marketing surveillance of immediate allergic reactions: polygeline-based versus polygeline-free pediatric TBE vaccine. Vaccine 23 (2004) 579-584
52. Weinzettel R., Ertl S., and Zwiauer K. FSME-Monitoring: Monitoring von Impfnebenwirkungen und -reaktionen auf die FSME-Impfung durch ausgewählte niedergelassene Pädiater und Allgemeinmediziner. Wien Med Wochenschr 157 (2007) 107-110
53. Loew-Baselli A., Konior R., Pavlova B.G., Fritsch S., Poellabauer E., Maritsch F., et al. Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies. Vaccine 24 (2006) 5256-5263
54. Rendi-Wagner P., Zent O., Jilg W., Plentz A., Beran J., and Kollaritsch H. Persistence of antibodies after vaccination against tick-borne encephalitis. Int J Med Microbiol 296 Suppl. 1 (2006) 202-207
55. Harabacz I., Bock H., Jüngst C., Klockmann U., Praus M., and Weber R. A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens. Vaccine 10 (1992) 145-150
56. Zent O., Beran J., Jilg W., Mach T., and Banzhoff A. Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults. Vaccine 21 (2003) 738-741
57. Schöndorf I., Beran J., Cizkova D., Lesna V., Banzhoff A., and Zent O. Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule. Vaccine 25 (2007) 1470-1475
58. Zent O., Banzhoff A., Hilbert A.K., Meriste S., Słuzewski W., and Wittermann C. Safety, immunogenicity and tolerability of a new paediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer. Vaccine 21 (2003) 3584-3592
59. Wittermann C., Nicolay U., Hilbert A., and Schoendorf I. Paediatric TBE vaccines: schedules to optimize protection. Int J Med Microbiol 298 Suppl. 1 (2008) S301-S304
60. Schöndorf I., Ternak G., Oroszlàn G., Nicolay U., Banzhoff A., and Zent O. Tick-borne encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21). Hum Vaccines 2 (2007) 42-47
61. Rendi-Wagner P., Paulke-Korinek M., Kundi M., Wiedermann U., Laaber B., and Kollaritsch H. Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up. Vaccine 25 (2007) 5097-5101
62. Zent O., Plentz A., Schwarz T.F., Frühwein N., Kuhr H.B., Broeker M., et al. TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?. Vaccine 23 (2004) 312-315
63. ® using the rapid immunization schedule. Int J Med Microbiol 293 Suppl. 37 (2004) 130-133
64. Schöndorf I., Schönfeld C., Nicolay U., Zent O., and Banzhoff A. Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time interval to primary immunization with the rapid schedule. Int J Med Microbiol 296 Suppl. 1 (2006) 208-212
65. Zent O., Jilg W., Plentz A., Schwarz T.F., Frühwein N., Kuhr H.B., et al. Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule. Vaccine 21 (2003) 4655-4660
66. Zent O., Schwarz T.F., Plentz A., Banzhoff A., and Jilg W. TBE booster immunization in adults - first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer. Int J Med Microbiol 293 (2004) 134-138
67. Rendi-Wagner P., Kundi M., Zent O., Dvorak G., Jaehnig P., Holzmann H., et al. Persistence of protective immunity following vaccination against tick-borne encephalitis - longer than expected?. Vaccine 22 (2004) 2743-2749
68. Rendi-Wagner P., Kundi M., Zent O., Banzhoff A., Jaehnig P., Stemberger R., et al. Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunization. Vaccine 23 (2004) 427-434
69. Rendi-Wagner P., Paulke-Korinek M., Kundi M., Wiedermann U., Laaber B., and Kollaritsch H. Seroprotection 4 years following booster vaccination against tick-borne encephalitis. Int J Med Microbiol 298 Suppl. 1 (2008) S308
70. Hainz U., Jenewein B., Asch E., Pfeiffer K.-P., Berger P., and Grubeck-Loebenstein B. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine 23 (2005) 3232-3235
71. Bröker M., and Schöndorf I. Are tick-borne encephalitis vaccines interchangeable?. Expert Rev Vaccines 5 (2006) 461-466
72. Kreil T.R., and Eibl M.M. Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model. J Virol 71 (1997) 2321-2327
73. Gollins S.W., and Porterfield J.S. Flavivirus infection enhancement in macrophages: radioactive and biological studies on the effect of antibody on viral fate. J Gen Virol 65 (1984) 1261-1272
74. Bröker M., and Kollaritsch H. After a tick bite in a tick-borne encephalitis virus endemic area: current positions about post-exposure treatment. Vaccine 26 (2008) 863-868
75. Heinz F.X., Holzmann H., Essl A., and Kundi M. Field effectiveness of vaccination against tick-borne encephalitis. Vaccine 25 (2007) 7559-7567
76. Kunz C. TBE vaccination and the Austrian experience. Vaccine 21 Suppl. 1 (2003) S50-S55
77. Heinz FX, Holzmann H. Bilanz der FSME Saison, 2007. Virusepidemiologische Information Nr. 04/08.
78. Kunze U., Asokliene L., Bektimirov T., Busse A., Chmelik V., Heinz F.X., et al. Tick-borne encephalitis in childhood - consensus 2004. Wien Med Wochenschr 154 (2004) 242-245
79. Kunze U., Baumhackl U., Bretschneider R., Chmelik V., Grubeck-Loebenstein B., Haglund M., et al. The Golden Agers and tick-borne encephalitis. Conference report and position paper of the International Scientific Working Group on tick-borne encephalitis. Wien Med Wochenschr 155 (2005) 289-294
80. Kunze U., and ISW-TBE. Tick-borne encephalitis - a European health challenge. Conference report of the eighth meeting of the International Scientific Working Group on Tick-borne Encephalitis (ISW TBE). Wien Med Wochenschr 156 (2006) 376-378
81. World Tourism Organization. Tourism Highlights (2007). http://www.unwto.org